Editorial & Opinion

Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.

التفاصيل البيبلوغرافية
العنوان: Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19.
المؤلفون: De Wilton A; Hospital for Tropical Diseases, University College Hospitals London NHS Foundation Trust, London, United Kingdom. Electronic address: angus.dewilton@nhs.net., Nabarro LE; Hospital for Tropical Diseases, University College Hospitals London NHS Foundation Trust, London, United Kingdom. Electronic address: laura.nabarro@nhs.net., Godbole GS; Hospital for Tropical Diseases, University College Hospitals London NHS Foundation Trust, London, United Kingdom. Electronic address: gauri.godbole@nhs.net., Chiodini PL; Hospital for Tropical Diseases, University College Hospitals London NHS Foundation Trust, London, United Kingdom. Electronic address: p.chiodini@nhs.net., Boyd A; Homerton University Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: aileen.boyd@nhs.net., Woods K; Homerton University Hospital NHS Foundation Trust, London, United Kingdom. Electronic address: katherine.woods3@nhs.net.
المصدر: Travel medicine and infectious disease [Travel Med Infect Dis] 2021 Mar-Apr; Vol. 40, pp. 101981. Date of Electronic Publication: 2021 Jan 31.
نوع المنشور: Letter; Comment
اللغة: English
بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 101230758 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-0442 (Electronic) Linking ISSN: 14778939 NLM ISO Abbreviation: Travel Med Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Amsterdam : Elsevier Science, 2003-
مواضيع طبية MeSH: Strongyloides stercoralis* , Strongyloidiasis*/drug therapy , COVID-19 Drug Treatment*, Animals ; Dexamethasone/adverse effects ; Humans ; SARS-CoV-2 ; Steroids
التعليقات: Comment on: JAMA. 2020 Jul 30;:null. (PMID: 32761166)
References: Travel Med Infect Dis. 2020 Sep - Oct;37:101844. (PMID: 32791213)
Infection. 2021 Jun;49(3):539-542. (PMID: 32910321)
JAMA. 2020 Aug 18;324(7):623-624. (PMID: 32761166)
Am J Trop Med Hyg. 2019 Aug;101(2):428-431. (PMID: 31219002)
Am J Trop Med Hyg. 2020 Oct;103(4):1590-1592. (PMID: 32830642)
Lancet Infect Dis. 2019 Nov;19(11):1181-1190. (PMID: 31558376)
المشرفين على المادة: 0 (Steroids)
7S5I7G3JQL (Dexamethasone)
تواريخ الأحداث: Date Created: 20210203 Date Completed: 20210402 Latest Revision: 20221221
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC7847532
DOI: 10.1016/j.tmaid.2021.101981
PMID: 33535106
قاعدة البيانات: MEDLINE
الوصف
تدمد:1873-0442
DOI:10.1016/j.tmaid.2021.101981